Investor Presentaiton

Solid progress on HeyloTM and Luja™; Luja is launched in five markets and is expected to be available in key markets over the next 6 months Status August 2023 Luja™M new catheter • platform Heylo™ digital leakage notification system Expected launch • Product launched in five markets Coloplast has presented the results of its second pivotal clinical study on Luja, confirming the improved performance of Luja seen in the first study¹) Product launch expected in key markets over the next 6 months CE mark has been granted • Payer pilot studies in Germany and the UK progressing as planned, with good user feedback Product launch expected in 2023 Simultaneously, continue our launch cadence into existing categories within ostomy care and continence care Luja is a medical device for which CE-mark has been affixed. Product availability is subject to regulatory process of individual countries and is not guaranteed. 31 1) The data set presented at the INUS annual congress and other relevant clinical data on Luja is available via this link. Coloplast

View entire presentation